Bristol Letters Warn Of Hydroxyurea-Related Ulcers And Gangrene
This article was originally published in The Pink Sheet Daily
Bristol is cautioning providers to take precautions when handling its Hydrea cancer treatment and Droxia sickle cell anemia therapy.
You may also be interested in...
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
Agency begins gathering manufacturing plant data to prepare for disruptions that can drain inventories over a weekend.